Skip to content

To determine whether Ai-chi exercises (aquatic exercises) can improve balance, functional status and quality of life in patients with Parkinson's disease

Effects of Ai-Chi on balance and clinical manifestations in patients with Parkinson's disease: A randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26292510
Enrollment
40
Registered
2016-02-19
Start date
2015-02-15
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease Nervous System Diseases Parkinson's disease

Interventions

Participants are randomised to one of two groups. Intervention group: Participants attend hour-long sessions, five times a week for five weeks, in which they complete Ai-Chi-exercises

Sponsors

Ahi Evran University Medical Faculty Educational and Research Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Ability to follow a stable medication schedule 2. In Parkinson Disease stages 2 to 3 according to the Hoehn and Yahr Scale 1 3. Lack of dementia (Mini-Mental State Examination score =24) 4. All patients’ BMI were between 18 and 30

Exclusion criteria

Exclusion criteria: 1. Having participated in physical therapy in the previous six months 2. Fear of water 3. Allergy to chlorine 4. Inability to walk independently 5. Having undergone surgical treatment for Parkinson's Disease 6. History or evidence of neurological deficit other than Parkinson's Disease (stroke, neuromuskuler disease, etc.) 7. Uncontrolled hypertension 8. Diabetes 9. incontinence 10. Open wounds 11. Osteoarthritis 12. Osteoporosis at a level that impairs walking and balance

Design outcomes

Primary

MeasureTime frame
1. Balance is measured using Biodex-3,1 and Berg Balance Scores at baseline and 5 weeks 2. Mobility is assessed using the Time Up Go Test at baseline and 5 weeks 3. Motor ability and quality of life, assessed using Parkinson's disease Questionnaire-39 and the Unified Parkinson Disease Rating Scale-III (UPDS-III) at baseline and 5 weeks

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 11, 2026